Global Central Lab Market

Central Lab Comprehensive Study by Type (Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Others), Application (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes) Players and Region - Global Market Outlook to 2030

Central Lab Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Central Lab Market Scope
To meet the demands of today's drug, device, and diagnostics development environments, a next-generation service provider is required. When looking for a long-term central laboratory solution, it is critical to find a partner who can meet your needs across a wide range of central laboratory services. Pharmaceutical companies are looking for ways to reduce the cost of product development and manufacturing. One of the most common services that these companies outsource is central lab services. Aside from cost savings, the use of central labs speeds up the drug development process. Pharmaceutical and biopharmaceutical companies typically completely outsource their central labs. Many CROs are interested in central lab services because they provide bundled services that allow them to accept a wide range of services.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledACM Global Central Lab (India), Barc Lab (Cerba Research) (Belgium), Bioscientia (Sonic Healthcare) (Germany), Celerion (Switzerland), CIRION BioPharma Research (Canada), Clinical Reference Laboratory (United States), Lab Corp/Covance (India), Eurofins Central Laboratory(Luxembourg), Frontage Laboratories, Inc. (United States) and ICON Central Labs (Ireland)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Central Lab market throughout the predicted period.

ACM Global Central Lab (India), Barc Lab (Cerba Research) (Belgium), Bioscientia (Sonic Healthcare) (Germany), Celerion (Switzerland), CIRION BioPharma Research (Canada), Clinical Reference Laboratory (United States), Lab Corp/Covance (India), Eurofins Central Laboratory(Luxembourg), Frontage Laboratories, Inc. (United States) and ICON Central Labs (Ireland) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Central Lab market by Type , by Application (Pharmaceutical Companies, Biotechnology Companies and Academic and Research Institutes) and Region with country level break-up.

On the basis of geography, the market of Central Lab has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.




Influencing Trend:
The combination of an aging population and a scarcity of healthcare professionals has created an opportunity for the Central Lab market to expand in these areas.

Market Growth Drivers:
Some of the factors influencing the growth of the central lab market include an increase in the number of clinical trials, lower trial costs, and advancements in new therapies and drugs.

Challenges:
Lack of affordability in the developing regions

Restraints:
Stringent government regulations

Opportunities:
The growing complexity of clinical trials and their environments has resulted in the establishment and expansion of a number of central labs around the world.

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Central Lab Providers, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Genetic Services
  • Biomarker Services
  • Microbiology Services
  • Anatomic Pathology/Histology
  • Specimen Management & Storage
  • Special Chemistry Services
  • Others
By Application
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Some of the factors influencing the growth of the central lab market include an increase in the number of clinical trials, lower trial costs, and advancements in new therapies and drugs.
    • 3.3. Market Challenges
      • 3.3.1. Lack of affordability in the developing regions
    • 3.4. Market Trends
      • 3.4.1. The combination of an aging population and a scarcity of healthcare professionals has created an opportunity for the Central Lab market to expand in these areas.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Central Lab, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Central Lab (Value)
      • 5.2.1. Global Central Lab by: Type (Value)
        • 5.2.1.1. Genetic Services
        • 5.2.1.2. Biomarker Services
        • 5.2.1.3. Microbiology Services
        • 5.2.1.4. Anatomic Pathology/Histology
        • 5.2.1.5. Specimen Management & Storage
        • 5.2.1.6. Special Chemistry Services
        • 5.2.1.7. Others
      • 5.2.2. Global Central Lab by: Application (Value)
        • 5.2.2.1. Pharmaceutical Companies
        • 5.2.2.2. Biotechnology Companies
        • 5.2.2.3. Academic and Research Institutes
      • 5.2.3. Global Central Lab Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Central Lab: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ACM Global Central Lab (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Barc Lab (Cerba Research) (Belgium)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bioscientia (Sonic Healthcare) (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Celerion (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CIRION BioPharma Research (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Clinical Reference Laboratory (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lab Corp/Covance (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eurofins Central Laboratory(Luxembourg)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Frontage Laboratories, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ICON Central Labs (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Central Lab Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Central Lab (Value)
      • 7.2.1. Global Central Lab by: Type (Value)
        • 7.2.1.1. Genetic Services
        • 7.2.1.2. Biomarker Services
        • 7.2.1.3. Microbiology Services
        • 7.2.1.4. Anatomic Pathology/Histology
        • 7.2.1.5. Specimen Management & Storage
        • 7.2.1.6. Special Chemistry Services
        • 7.2.1.7. Others
      • 7.2.2. Global Central Lab by: Application (Value)
        • 7.2.2.1. Pharmaceutical Companies
        • 7.2.2.2. Biotechnology Companies
        • 7.2.2.3. Academic and Research Institutes
      • 7.2.3. Global Central Lab Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Central Lab: by Type(USD Million)
  • Table 2. Central Lab Genetic Services , by Region USD Million (2018-2023)
  • Table 3. Central Lab Biomarker Services , by Region USD Million (2018-2023)
  • Table 4. Central Lab Microbiology Services , by Region USD Million (2018-2023)
  • Table 5. Central Lab Anatomic Pathology/Histology , by Region USD Million (2018-2023)
  • Table 6. Central Lab Specimen Management & Storage , by Region USD Million (2018-2023)
  • Table 7. Central Lab Special Chemistry Services , by Region USD Million (2018-2023)
  • Table 8. Central Lab Others , by Region USD Million (2018-2023)
  • Table 9. Central Lab: by Application(USD Million)
  • Table 10. Central Lab Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 11. Central Lab Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 12. Central Lab Academic and Research Institutes , by Region USD Million (2018-2023)
  • Table 13. South America Central Lab, by Country USD Million (2018-2023)
  • Table 14. South America Central Lab, by Type USD Million (2018-2023)
  • Table 15. South America Central Lab, by Application USD Million (2018-2023)
  • Table 16. Brazil Central Lab, by Type USD Million (2018-2023)
  • Table 17. Brazil Central Lab, by Application USD Million (2018-2023)
  • Table 18. Argentina Central Lab, by Type USD Million (2018-2023)
  • Table 19. Argentina Central Lab, by Application USD Million (2018-2023)
  • Table 20. Rest of South America Central Lab, by Type USD Million (2018-2023)
  • Table 21. Rest of South America Central Lab, by Application USD Million (2018-2023)
  • Table 22. Asia Pacific Central Lab, by Country USD Million (2018-2023)
  • Table 23. Asia Pacific Central Lab, by Type USD Million (2018-2023)
  • Table 24. Asia Pacific Central Lab, by Application USD Million (2018-2023)
  • Table 25. China Central Lab, by Type USD Million (2018-2023)
  • Table 26. China Central Lab, by Application USD Million (2018-2023)
  • Table 27. Japan Central Lab, by Type USD Million (2018-2023)
  • Table 28. Japan Central Lab, by Application USD Million (2018-2023)
  • Table 29. India Central Lab, by Type USD Million (2018-2023)
  • Table 30. India Central Lab, by Application USD Million (2018-2023)
  • Table 31. South Korea Central Lab, by Type USD Million (2018-2023)
  • Table 32. South Korea Central Lab, by Application USD Million (2018-2023)
  • Table 33. Taiwan Central Lab, by Type USD Million (2018-2023)
  • Table 34. Taiwan Central Lab, by Application USD Million (2018-2023)
  • Table 35. Australia Central Lab, by Type USD Million (2018-2023)
  • Table 36. Australia Central Lab, by Application USD Million (2018-2023)
  • Table 37. Rest of Asia-Pacific Central Lab, by Type USD Million (2018-2023)
  • Table 38. Rest of Asia-Pacific Central Lab, by Application USD Million (2018-2023)
  • Table 39. Europe Central Lab, by Country USD Million (2018-2023)
  • Table 40. Europe Central Lab, by Type USD Million (2018-2023)
  • Table 41. Europe Central Lab, by Application USD Million (2018-2023)
  • Table 42. Germany Central Lab, by Type USD Million (2018-2023)
  • Table 43. Germany Central Lab, by Application USD Million (2018-2023)
  • Table 44. France Central Lab, by Type USD Million (2018-2023)
  • Table 45. France Central Lab, by Application USD Million (2018-2023)
  • Table 46. Italy Central Lab, by Type USD Million (2018-2023)
  • Table 47. Italy Central Lab, by Application USD Million (2018-2023)
  • Table 48. United Kingdom Central Lab, by Type USD Million (2018-2023)
  • Table 49. United Kingdom Central Lab, by Application USD Million (2018-2023)
  • Table 50. Netherlands Central Lab, by Type USD Million (2018-2023)
  • Table 51. Netherlands Central Lab, by Application USD Million (2018-2023)
  • Table 52. Rest of Europe Central Lab, by Type USD Million (2018-2023)
  • Table 53. Rest of Europe Central Lab, by Application USD Million (2018-2023)
  • Table 54. MEA Central Lab, by Country USD Million (2018-2023)
  • Table 55. MEA Central Lab, by Type USD Million (2018-2023)
  • Table 56. MEA Central Lab, by Application USD Million (2018-2023)
  • Table 57. Middle East Central Lab, by Type USD Million (2018-2023)
  • Table 58. Middle East Central Lab, by Application USD Million (2018-2023)
  • Table 59. Africa Central Lab, by Type USD Million (2018-2023)
  • Table 60. Africa Central Lab, by Application USD Million (2018-2023)
  • Table 61. North America Central Lab, by Country USD Million (2018-2023)
  • Table 62. North America Central Lab, by Type USD Million (2018-2023)
  • Table 63. North America Central Lab, by Application USD Million (2018-2023)
  • Table 64. United States Central Lab, by Type USD Million (2018-2023)
  • Table 65. United States Central Lab, by Application USD Million (2018-2023)
  • Table 66. Canada Central Lab, by Type USD Million (2018-2023)
  • Table 67. Canada Central Lab, by Application USD Million (2018-2023)
  • Table 68. Mexico Central Lab, by Type USD Million (2018-2023)
  • Table 69. Mexico Central Lab, by Application USD Million (2018-2023)
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Central Lab: by Type(USD Million)
  • Table 81. Central Lab Genetic Services , by Region USD Million (2025-2030)
  • Table 82. Central Lab Biomarker Services , by Region USD Million (2025-2030)
  • Table 83. Central Lab Microbiology Services , by Region USD Million (2025-2030)
  • Table 84. Central Lab Anatomic Pathology/Histology , by Region USD Million (2025-2030)
  • Table 85. Central Lab Specimen Management & Storage , by Region USD Million (2025-2030)
  • Table 86. Central Lab Special Chemistry Services , by Region USD Million (2025-2030)
  • Table 87. Central Lab Others , by Region USD Million (2025-2030)
  • Table 88. Central Lab: by Application(USD Million)
  • Table 89. Central Lab Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 90. Central Lab Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 91. Central Lab Academic and Research Institutes , by Region USD Million (2025-2030)
  • Table 92. South America Central Lab, by Country USD Million (2025-2030)
  • Table 93. South America Central Lab, by Type USD Million (2025-2030)
  • Table 94. South America Central Lab, by Application USD Million (2025-2030)
  • Table 95. Brazil Central Lab, by Type USD Million (2025-2030)
  • Table 96. Brazil Central Lab, by Application USD Million (2025-2030)
  • Table 97. Argentina Central Lab, by Type USD Million (2025-2030)
  • Table 98. Argentina Central Lab, by Application USD Million (2025-2030)
  • Table 99. Rest of South America Central Lab, by Type USD Million (2025-2030)
  • Table 100. Rest of South America Central Lab, by Application USD Million (2025-2030)
  • Table 101. Asia Pacific Central Lab, by Country USD Million (2025-2030)
  • Table 102. Asia Pacific Central Lab, by Type USD Million (2025-2030)
  • Table 103. Asia Pacific Central Lab, by Application USD Million (2025-2030)
  • Table 104. China Central Lab, by Type USD Million (2025-2030)
  • Table 105. China Central Lab, by Application USD Million (2025-2030)
  • Table 106. Japan Central Lab, by Type USD Million (2025-2030)
  • Table 107. Japan Central Lab, by Application USD Million (2025-2030)
  • Table 108. India Central Lab, by Type USD Million (2025-2030)
  • Table 109. India Central Lab, by Application USD Million (2025-2030)
  • Table 110. South Korea Central Lab, by Type USD Million (2025-2030)
  • Table 111. South Korea Central Lab, by Application USD Million (2025-2030)
  • Table 112. Taiwan Central Lab, by Type USD Million (2025-2030)
  • Table 113. Taiwan Central Lab, by Application USD Million (2025-2030)
  • Table 114. Australia Central Lab, by Type USD Million (2025-2030)
  • Table 115. Australia Central Lab, by Application USD Million (2025-2030)
  • Table 116. Rest of Asia-Pacific Central Lab, by Type USD Million (2025-2030)
  • Table 117. Rest of Asia-Pacific Central Lab, by Application USD Million (2025-2030)
  • Table 118. Europe Central Lab, by Country USD Million (2025-2030)
  • Table 119. Europe Central Lab, by Type USD Million (2025-2030)
  • Table 120. Europe Central Lab, by Application USD Million (2025-2030)
  • Table 121. Germany Central Lab, by Type USD Million (2025-2030)
  • Table 122. Germany Central Lab, by Application USD Million (2025-2030)
  • Table 123. France Central Lab, by Type USD Million (2025-2030)
  • Table 124. France Central Lab, by Application USD Million (2025-2030)
  • Table 125. Italy Central Lab, by Type USD Million (2025-2030)
  • Table 126. Italy Central Lab, by Application USD Million (2025-2030)
  • Table 127. United Kingdom Central Lab, by Type USD Million (2025-2030)
  • Table 128. United Kingdom Central Lab, by Application USD Million (2025-2030)
  • Table 129. Netherlands Central Lab, by Type USD Million (2025-2030)
  • Table 130. Netherlands Central Lab, by Application USD Million (2025-2030)
  • Table 131. Rest of Europe Central Lab, by Type USD Million (2025-2030)
  • Table 132. Rest of Europe Central Lab, by Application USD Million (2025-2030)
  • Table 133. MEA Central Lab, by Country USD Million (2025-2030)
  • Table 134. MEA Central Lab, by Type USD Million (2025-2030)
  • Table 135. MEA Central Lab, by Application USD Million (2025-2030)
  • Table 136. Middle East Central Lab, by Type USD Million (2025-2030)
  • Table 137. Middle East Central Lab, by Application USD Million (2025-2030)
  • Table 138. Africa Central Lab, by Type USD Million (2025-2030)
  • Table 139. Africa Central Lab, by Application USD Million (2025-2030)
  • Table 140. North America Central Lab, by Country USD Million (2025-2030)
  • Table 141. North America Central Lab, by Type USD Million (2025-2030)
  • Table 142. North America Central Lab, by Application USD Million (2025-2030)
  • Table 143. United States Central Lab, by Type USD Million (2025-2030)
  • Table 144. United States Central Lab, by Application USD Million (2025-2030)
  • Table 145. Canada Central Lab, by Type USD Million (2025-2030)
  • Table 146. Canada Central Lab, by Application USD Million (2025-2030)
  • Table 147. Mexico Central Lab, by Type USD Million (2025-2030)
  • Table 148. Mexico Central Lab, by Application USD Million (2025-2030)
  • Table 149. Research Programs/Design for This Report
  • Table 150. Key Data Information from Secondary Sources
  • Table 151. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Central Lab: by Type USD Million (2018-2023)
  • Figure 5. Global Central Lab: by Application USD Million (2018-2023)
  • Figure 6. South America Central Lab Share (%), by Country
  • Figure 7. Asia Pacific Central Lab Share (%), by Country
  • Figure 8. Europe Central Lab Share (%), by Country
  • Figure 9. MEA Central Lab Share (%), by Country
  • Figure 10. North America Central Lab Share (%), by Country
  • Figure 11. Global Central Lab share by Players 2023 (%)
  • Figure 12. Global Central Lab share by Players (Top 3) 2023(%)
  • Figure 13. Global Central Lab share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. ACM Global Central Lab (India) Revenue, Net Income and Gross profit
  • Figure 16. ACM Global Central Lab (India) Revenue: by Geography 2023
  • Figure 17. Barc Lab (Cerba Research) (Belgium) Revenue, Net Income and Gross profit
  • Figure 18. Barc Lab (Cerba Research) (Belgium) Revenue: by Geography 2023
  • Figure 19. Bioscientia (Sonic Healthcare) (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bioscientia (Sonic Healthcare) (Germany) Revenue: by Geography 2023
  • Figure 21. Celerion (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. Celerion (Switzerland) Revenue: by Geography 2023
  • Figure 23. CIRION BioPharma Research (Canada) Revenue, Net Income and Gross profit
  • Figure 24. CIRION BioPharma Research (Canada) Revenue: by Geography 2023
  • Figure 25. Clinical Reference Laboratory (United States) Revenue, Net Income and Gross profit
  • Figure 26. Clinical Reference Laboratory (United States) Revenue: by Geography 2023
  • Figure 27. Lab Corp/Covance (India) Revenue, Net Income and Gross profit
  • Figure 28. Lab Corp/Covance (India) Revenue: by Geography 2023
  • Figure 29. Eurofins Central Laboratory(Luxembourg) Revenue, Net Income and Gross profit
  • Figure 30. Eurofins Central Laboratory(Luxembourg) Revenue: by Geography 2023
  • Figure 31. Frontage Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Frontage Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 33. ICON Central Labs (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. ICON Central Labs (Ireland) Revenue: by Geography 2023
  • Figure 35. Global Central Lab: by Type USD Million (2025-2030)
  • Figure 36. Global Central Lab: by Application USD Million (2025-2030)
  • Figure 37. South America Central Lab Share (%), by Country
  • Figure 38. Asia Pacific Central Lab Share (%), by Country
  • Figure 39. Europe Central Lab Share (%), by Country
  • Figure 40. MEA Central Lab Share (%), by Country
  • Figure 41. North America Central Lab Share (%), by Country
List of companies from research coverage that are profiled in the study
  • ACM Global Central Lab (India)
  • Barc Lab (Cerba Research) (Belgium)
  • Bioscientia (Sonic Healthcare) (Germany)
  • Celerion (Switzerland)
  • CIRION BioPharma Research (Canada)
  • Clinical Reference Laboratory (United States)
  • Lab Corp/Covance (India)
  • Eurofins Central Laboratory(Luxembourg)
  • Frontage Laboratories, Inc. (United States)
  • ICON Central Labs (Ireland)
Select User Access Type

Key Highlights of Report


Feb 2024 228 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Central Lab Market Quantitative research analysis
Global Central Lab Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Central Lab Market are by type [Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services and Others], by end use application [Pharmaceutical Companies, Biotechnology Companies and Academic and Research Institutes].
The Central Lab Market is gaining popularity and expected to see strong valuation by 2030.
  • Some of the factors influencing the growth of the central lab market include an increase in the number of clinical trials, lower trial costs, and advancements in new therapies and drugs.

Know More About Global Central Lab Market Report?

Have a Query? Click Here

Other Related Reports

Wooden Watch Comprehensive Study by Type (Analog, Digital), Category (Casual Wear, Formal Wear), Size (Small, Medium, XL), Distribution (Franchise Stores, Third Party Sales, E-Commerce Websites, Reta...
$ 3350
VCSEL for Data Communication Comprehensive Study by Type (Single-Mode, Multimode), Data Rate (Upto 10 Gbps, 10.1 to 25 Gbps, Above 25 Gbps), Material (Gallium Nitride (GaN), Gallium Arsenide (GaAs), ...
$ 3450
Virtual Synchronous Machine Comprehensive Study by Application (Power Electronic converters, Energy Storage System, Renewable Energy Sources, Controlled Voltage Source, Others), Components (System, S...
$ 3750
Transtympanic Injectable Comprehensive Study by Drugs (Corticosteroid, Aminoglycosides), End Users (Hospitals, ENT Clinics, Others) Players and Region - Global Market Outlook to 2026
$ 3500
Hormonal Therapy Comprehensive Study by Therapy (Estrogen Hormone Therapy, Human Growth Hormone Therapy, Thyroid Hormone Therapy, Testosterone Hormone Therapy, Progestogen Hormone Therapy, Others), A...
$ 3650
6G Technology Comprehensive Study by Application (Smart Cities, Satellite Communication, Data Connection, Others), Technology (Terahertz (Thz) Band, Artificial Intelligence (AI), Optical Wireless Com...
$ 3650